The global home infusion therapy market size was valued at USD 41.65 billion in 2025 and is projected to grow from USD 44.99 billion in 2026 to USD 83.47 billion by 2034, registering a CAGR of 8.03% during the forecast period from 2026 to 2034. North America dominated the home infusion therapy market with a market share of 42.6% in 2025.
The rising prevalence of chronic diseases, including diabetes, cancer, and immune disorders, is driving demand for long-term intravenous therapies administered at home. The International Diabetes Federation 2025 stated that approximately 589 million adults aged 20-79 are living with diabetes.
Clinical studies indicate that home infusion can lower hospitalization rates by over 20% while enhancing patient satisfaction and adherence.Expanding aging populations and increased preference for cost-effective care settings further accelerate market growth. Opportunities are emerging through partnerships with home healthcare providers, specialty pharmacies, and digital health platforms.
Download a Free Sample To learn more about this report,
Increasing Shift Toward Home-Based and Patient-Centered Infusion Care
Home infusion therapy is increasingly being adopted as an alternative to prolonged hospital-based treatment for patients requiring intravenous or subcutaneous therapies. The shift toward home care can reduce facility visits, improve patient mobility, and support treatment continuity while helping healthcare systems manage costs and capacity more efficiently.
Growing Integration of Smart Infusion Devices and Remote Monitoring Technologies
Home infusion services are increasingly incorporating portable smart infusion pumps, wireless connectivity, telehealth platforms, and remote monitoring capabilities. These technologies enable healthcare professionals to track therapy remotely, identify potential complications, support adherence, and adjust treatment plans while reducing the need for frequent in-person visits.
Rising Prevalence of Chronic Diseases and Increasing Need for Prolonged Infusion Therapies Support Home Infusion Therapy Market Growth
The increasing prevalence of cancer, diabetes, immune deficiencies, chronic infections, and other conditions requiring prolonged medication administration is expanding the overall need for infusion therapies. The growing use of intravenous antibiotics, immunoglobulins, specialty pharmaceuticals, nutrition therapies, and other infused treatments is increasing demand for reliable infusion services across healthcare settings and supporting continued market growth.
High Costs and Complex Care Coordination Requirements Can Limit Home Infusion Therapy Adoption
Home infusion therapy requires infusion equipment, medications, nursing support, patient training, vascular access management, monitoring, and coordination among healthcare providers and pharmacies. These requirements can increase service costs and operational complexity, particularly for patients with limited caregiver support or healthcare systems with restricted reimbursement coverage.
Expansion of Specialty Pharmaceuticals and Complex Therapies in Home Settings Creates New Growth Opportunities
The growing availability of biologics, immunoglobulin therapies, specialty pharmaceuticals, anti-infectives, and other complex treatments is expanding the range of therapies that can potentially be delivered at home. Improvements in patient selection, clinical support, portable infusion technologies, and remote monitoring can enable more high-value therapies to transition from institutional settings to coordinated home-care programs.
Maintaining Infection Control, Patient Safety, and Reliable Clinical Monitoring Creates Challenges
Home infusion therapy requires strict medication handling, vascular access care, infection-control procedures, accurate device operation, and timely clinical intervention when complications occur. Delivering these requirements outside controlled healthcare facilities can create challenges related to patient training, caregiver capability, monitoring consistency, emergency response, and maintaining high standards of clinical quality.
The products segment accounted for a share of 61.5% in 2025, owing to the widespread use of infusion pumps, intravenous solutions, administration sets, and other medical products required for home-based infusion therapy. the increasing adoption of home healthcare and growing demand for convenient and cost-effective treatment options further strengthen the segment’s dominant position in the home infusion therapy market.
The services segment is expected to grow at a CAGR of 8.9% during the forecast period, driven by increasing demand for skilled home infusion care, growing preference for home-based treatment, and rising need for patient monitoring and clinical support. the expansion of home healthcare services and increasing availability of specialized infusion therapy providers further support the segment’s growth.
Request Customizationto receive a tailored report.
The infusion pumps segment accounted for a 43.2% share in 2025 and is expected to grow at a CAGR of 8.7% during the forecast period 2026-2034, driven by increasing demand for controlled and accurate drug delivery, growing adoption of home-based infusion therapy, and rising prevalence of chronic conditions requiring long-term treatment. the increasing use of portable and technologically advanced infusion pumps further strengthens the segment’s dominant position in the home infusion therapy market.
The intravenous sets segment supports the administration of medications and fluids during infusion therapy, while the IV cannulas segment enables reliable vascular access for home-based treatments. the needleless connectors segment contributes to safer and more convenient infusion procedures by reducing needle-related risks and supporting efficient connections within infusion systems.
The anti-infective segment accounted for a share of 24.7% in 2025 due to the widespread use of home infusion therapy for administering antibiotics and other anti-infective medications, along with the growing need for long-term treatment of infections. the increasing preference for home-based care and the need to reduce hospital stays further strengthen the segment’s dominant position in the home infusion therapy market.
The specialty pharmaceuticals segment is expected to grow at a CAGR of 9.4% during the forecast period, fueled by increasing use of complex biologic and specialty medicines, growing prevalence of chronic and complex diseases, and rising demand for home-based administration of specialized therapies. the endocrinology segment supports infusion-based treatment for diabetes and other endocrine disorders, while the hydration therapy segment contributes through fluid replacement and management of dehydration. the chemotherapy segment supports cancer treatment through home-based administration of selected therapies, while the enteral nutrition segment provides nutritional support for patients unable to consume adequate nutrition orally. the parenteral nutrition segment supports patients requiring intravenous nutritional therapy.
Speak to an Analystto discuss market opportunities.
North America home infusion therapy market accounted for 42.6% of the global market, reaching USD 17.74 billion in 2025, and is projected to grow at a CAGR of 7.9% during the forecast period. The market is driven by increasing prevalence of chronic diseases, growing demand for home-based healthcare, rising healthcare costs, and increasing preference for convenient and personalized treatment options. Expanding home healthcare infrastructure and advancements in infusion technologies continue to support regional market growth.
The US market was valued at USD 15.08 billion in 2025, making it the largest contributor in North America. Increasing demand for home-based treatment, growing prevalence of chronic conditions, rising healthcare expenditure, and expanding adoption of portable infusion devices continue to drive market growth.
Canada's market reached USD 2.66 billion in 2025. Growing demand for home healthcare services, increasing aging population, expanding access to infusion therapy, and rising adoption of advanced home infusion technologies continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe home infusion therapy market accounted for 27.8% of the global market, reaching USD 11.58 billion in 2025, and is projected to grow at a CAGR of 7.6% during the forecast period. Increasing prevalence of chronic diseases, growing adoption of home healthcare services, rising healthcare expenditure, and increasing demand for cost-effective treatment alternatives continue to strengthen regional market growth. Expanding healthcare infrastructure and greater patient preference for home-based care further support market expansion.
The UK market was valued at USD 2.32 billion in 2025. Increasing demand for community-based healthcare, growing prevalence of chronic diseases, expanding home treatment programs, and rising adoption of advanced infusion technologies continue to support market growth.
Germany market accounted for USD 3.24 billion in 2025. Strong healthcare infrastructure, increasing demand for home-based medical care, growing elderly population, and rising investments in advanced infusion systems continue to drive market expansion.
Asia Pacific home infusion therapy market accounted for 19.7% of the global market, reaching USD 8.21 billion in 2025, and is projected to grow at a CAGR of 10.3% during the forecast period. Rapid healthcare infrastructure development, increasing prevalence of chronic diseases, growing healthcare expenditure, and rising demand for home-based treatment continue to accelerate regional market growth. Increasing awareness of home healthcare and expanding access to advanced infusion technologies further strengthen market expansion.
China's market accounted for USD 3.45 billion in 2025, representing the largest share within Asia Pacific. Expanding healthcare infrastructure, increasing demand for home-based care, growing chronic disease burden, and rising investments in healthcare technologies continue to drive market expansion.
Japan's market generated USD 1.48 billion in 2025. Increasing elderly population, growing demand for home healthcare, expanding adoption of portable infusion devices, and rising healthcare modernization continue to support market growth.
Middle East and Africa home infusion therapy market accounted for 4.1% of the global market, totaling USD 1.71 billion in 2025, and is projected to grow at a CAGR of 7.4% during the forecast period. Increasing investments in healthcare infrastructure, growing prevalence of chronic diseases, expanding home healthcare services, and rising awareness of home-based treatment options continue to support regional market growth.
The UAE market was valued at USD 0.43 billion in 2025. Increasing investments in advanced healthcare infrastructure, growing demand for home-based medical services, expanding private healthcare facilities, and rising adoption of innovative infusion technologies continue to drive market growth.
Africa's market reached USD 1.28 billion in 2025. Expanding healthcare access, increasing investments in healthcare infrastructure, growing demand for affordable home-based treatment, and rising awareness of infusion therapy continue to create long-term growth opportunities across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Germany Surgical Equipment Market Size, Share and Forecast to 2034
Europe Surgical Equipment Market Size, Top Share and Forecast to 2034
Biofeedback Instrument Market Size, Share, Growth, Analysis, 2034
Cardiac Assist Devices Market Size, Share, Growth, 2034
Radiosurgery Market Size, Share, Growth, Analysis, Report, 2034
Interventional Cardiology Devices Market Size, Share, Growth, 2034
We are featured on:
sales@straitsresearch.com